Less Task, More Talk
How Can We Help You
LEAD CONVERSION
Here’s how easy it can work for your business… #1 – You provide us with your unconverted leads. #2 – We then process your leads through our system and refer converted leads back to your business.
Please fill our form below for more information.
How Can We Help You
Schedule A Free Consultation
The old, manual way is a thing of the past.
The time is now to try the PERSIST way.
Taking the time to screen new customers is time-consuming and takes you away from other, more important tasks. Let our team of seasoned experts and our proven methods help you grow your business.
Contact us for a free consultation today at 1-866-473-7747.
Google Updated Algorithm
GOOGLE UPDATED ITS ALGORITHM AGAIN – WHY DO I CARE? Many of us have heard about Google updating, but may not be sure what that means or if it even affects you or your business. Fortunately, or unfortunately, it certainly [...]
LEAD GENERATION MADE SIMPLE
FOLLOW THE LEAD GENERATION LEADER All businesses need clients to prosper, but how do they find these clients? Through a lead generation and lead procurement system. And, most importantly, measuring all lead generation and procurement efforts across every channel of [...]
LATEST ON JOHNSON & JOHNSON AND THE RISPERDAL LAWSUIT
In a Philadelphia court, Johnson & Johnson (J&J) just paid out its largest award yet, $70 million for their prescription drug Risperdal (Risperidone). Criminal charges are tied to allegations that the company marketed the drug for off-label use. Off-label use [...]
A Typical Day with PERSIST Software
Persist software only requires two staff members to take incoming calls, generated from our intelligent call center software. In one day, 628 phone calls are made, with 221 voice mails generated automatically, 171 actual connections with prospective clients, 364 emails [...]
Making 2016 the Best Year of Your Law Practice
2015 is out and 2016 is in...does your firm have what it takes to make 2016 the best year of your law practice? Most of us are reflecting on what we accomplished compared to what we had hoped. What will [...]
FDA Concludes Invokana, SGLT2 Inhibitors, Pose Serious Risks
Friday, December 4, the FDA announced that its concerns about SGLT2 inhibitors were confirmed. FDA Concludes Invokana, SGLT2 Inhibitors, Pose Serious Risks. In May 2015, the FDA announced it was investigating the SGLT2 inhibitors (which include brands Invokana, Farxiga, Jardiance, Xigduo, [...]